Share Price and Basic Stock Data
Last Updated: October 10, 2025, 2:03 am
| PEG Ratio | 0.55 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Modi Naturals Ltd operates in the edible oils and solvent extraction industry, with its latest share price reported at ₹423 and a market capitalization of ₹554 Cr. The company’s revenue trajectory has shown fluctuations over the past few quarters. For instance, sales stood at ₹100 Cr in June 2022, peaked at ₹114 Cr in December 2022, and subsequently fell to ₹84 Cr in June 2023 before recovering to ₹92 Cr in September 2023. The trailing twelve months (TTM) sales reached ₹670 Cr, indicating a significant recovery from previous fiscal years, where annual revenues recorded ₹418 Cr in FY 2023 and ₹399 Cr in FY 2024. The sales growth for FY 2025 is robust, with reported figures suggesting a jump to ₹663 Cr, reflecting a recovery trend in the company’s financial performance. This growth can be associated with increasing consumer demand in the edible oils segment, although the company has faced challenges in maintaining consistent sales volumes. Overall, the revenue trends indicate volatility but a positive recovery outlook in recent quarters.
Profitability and Efficiency Metrics
In terms of profitability, Modi Naturals reported an operating profit margin (OPM) of 11%, showcasing its ability to generate profits relative to its sales. The company’s net profit stood at ₹31 Cr, translating to an impressive return on equity (ROE) of 29.2%. Despite some quarterly fluctuations—such as a decline to a net profit of ₹1 Cr in June 2023 and a loss of ₹2 Cr in March 2023—the overall trend indicates a strong rebound, with a net profit of ₹31 Cr for FY 2025. The interest coverage ratio (ICR) is robust at 4.89x, suggesting that the company has ample earnings to cover its interest obligations. However, the cash conversion cycle (CCC) of 66 days indicates room for improvement in operational efficiency, particularly in managing inventory and receivables. The profitability metrics suggest that while Modi Naturals has faced challenges, it has successfully navigated through them, demonstrating resilience in its financial performance.
Balance Sheet Strength and Financial Ratios
Modi Naturals’ balance sheet reflects a strategic approach to managing its liabilities and assets. The company reported total borrowings of ₹149 Cr against reserves of ₹108 Cr, indicating a debt-to-equity ratio of 1.22x, which is relatively high and suggests that the company is leveraging debt to finance its operations. The book value per share stood at ₹91.35, providing a solid foundation for its equity position. Liquidity ratios also reveal a current ratio of 1.22 and a quick ratio of 0.57, indicating adequate short-term financial health, although the quick ratio suggests potential challenges in immediate liquidity. The company’s return on capital employed (ROCE) at 18.6% shows effective utilization of capital in generating profits. Overall, while the balance sheet has areas of concern regarding high leverage, the profitability and asset management ratios signal a fundamentally strong financial position.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Modi Naturals Ltd reveals a strong promoter holding of 69.09%, indicating significant confidence from the founders and management in the company’s future. The public shareholding accounts for 30.92%, while foreign institutional investors (FIIs) have not reported any stake, and domestic institutional investors (DIIs) hold a negligible 0.00%. This concentrated ownership structure may lead to both opportunities and risks; while it suggests stability and commitment from promoters, it may also raise concerns regarding the lack of institutional backing. The number of shareholders has fluctuated, recently standing at 6,504, which is a slight decline from previous periods. The lack of significant DII participation could indicate hesitance from institutional investors, potentially due to the company’s past performance volatility. The overall shareholding dynamics indicate a mixed sentiment, with strong promoter confidence but limited institutional interest, suggesting a cautious outlook among broader investors.
Outlook, Risks, and Final Insight
If margins sustain and operational efficiencies improve, Modi Naturals could leverage its strong market position in the edible oils sector to enhance profitability further. However, risks persist, such as the company’s high debt levels, which could strain financial flexibility, particularly in adverse market conditions. Additionally, maintaining consistent sales growth amidst fluctuating consumer demand presents another challenge. The company’s ability to manage its cash conversion cycle effectively will be crucial in supporting liquidity and ensuring operational stability. Should Modi Naturals navigate these challenges successfully, it could solidify its market position and enhance shareholder value. The strategic focus on enhancing operational efficiencies and managing debt will be key to achieving long-term growth and sustainability in a competitive landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Modi Naturals Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modi Naturals Ltd | 539 Cr. | 411 | 667/320 | 15.8 | 92.8 | 0.00 % | 18.6 % | 29.2 % | 10.0 |
| IEL Ltd | 114 Cr. | 8.76 | 10.3/3.36 | 3.44 | 0.00 % | 2.51 % | 1.91 % | 1.00 | |
| Evexia Lifecare Ltd | 379 Cr. | 2.02 | 4.40/1.86 | 217 | 2.45 | 0.00 % | 0.30 % | 0.32 % | 1.00 |
| Diligent Industries Ltd | 76.8 Cr. | 3.22 | 5.12/1.45 | 28.5 | 2.71 | 0.00 % | 7.06 % | 6.09 % | 1.00 |
| CIAN Agro Industries & Infrastructure Ltd | 7,588 Cr. | 2,711 | 2,711/190 | 8,721 | 32.8 | 0.00 % | 8.54 % | 1.06 % | 10.0 |
| Industry Average | 9,929.07 Cr | 254.61 | 552.91 | 37.06 | 0.16% | 14.31% | 12.90% | 4.33 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 100 | 93 | 114 | 110 | 84 | 92 | 104 | 120 | 148 | 147 | 179 | 190 | 155 |
| Expenses | 95 | 91 | 113 | 113 | 81 | 90 | 106 | 114 | 134 | 133 | 166 | 174 | 137 |
| Operating Profit | 5 | 2 | 1 | -2 | 2 | 2 | -1 | 6 | 13 | 13 | 13 | 16 | 18 |
| OPM % | 5% | 2% | 1% | -2% | 3% | 2% | -1% | 5% | 9% | 9% | 7% | 8% | 11% |
| Other Income | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 3 | 3 | 3 | 3 | 2 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Profit before tax | 3 | 1 | 0 | -3 | 1 | 1 | -5 | 1 | 9 | 9 | 9 | 11 | 13 |
| Tax % | 25% | 25% | 0% | -13% | 16% | 16% | -15% | 6% | 14% | 15% | 12% | 27% | 22% |
| Net Profit | 3 | 1 | 0 | -2 | 1 | 1 | -4 | 1 | 7 | 8 | 8 | 8 | 10 |
| EPS in Rs | 2.06 | 0.60 | 0.01 | -1.83 | 0.62 | 0.60 | -3.20 | 0.96 | 5.70 | 5.79 | 5.97 | 6.23 | 8.01 |
Last Updated: August 19, 2025, 12:55 pm
Below is a detailed analysis of the quarterly data for Modi Naturals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 155.00 Cr.. The value appears to be declining and may need further review. It has decreased from 190.00 Cr. (Mar 2025) to 155.00 Cr., marking a decrease of 35.00 Cr..
- For Expenses, as of Jun 2025, the value is 137.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 174.00 Cr. (Mar 2025) to 137.00 Cr., marking a decrease of 37.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 18.00 Cr.. The value appears strong and on an upward trend. It has increased from 16.00 Cr. (Mar 2025) to 18.00 Cr., marking an increase of 2.00 Cr..
- For OPM %, as of Jun 2025, the value is 11.00%. The value appears strong and on an upward trend. It has increased from 8.00% (Mar 2025) to 11.00%, marking an increase of 3.00%.
- For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Interest, as of Jun 2025, the value is 2.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.00 Cr. (Mar 2025) to 2.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 11.00 Cr. (Mar 2025) to 13.00 Cr., marking an increase of 2.00 Cr..
- For Tax %, as of Jun 2025, the value is 22.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Mar 2025) to 22.00%, marking a decrease of 5.00%.
- For Net Profit, as of Jun 2025, the value is 10.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2025) to 10.00 Cr., marking an increase of 2.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 8.01. The value appears strong and on an upward trend. It has increased from 6.23 (Mar 2025) to 8.01, marking an increase of 1.78.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 23, 2025, 12:51 pm
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|
| Sales | 443 | 474 | 418 | 399 | 663 | 670 |
| Expenses | 430 | 459 | 412 | 390 | 607 | 610 |
| Operating Profit | 13 | 15 | 5 | 9 | 56 | 60 |
| OPM % | 3% | 3% | 1% | 2% | 8% | 9% |
| Other Income | 4 | 1 | 2 | 1 | 1 | 2 |
| Interest | 1 | 2 | 4 | 8 | 12 | 12 |
| Depreciation | 1 | 1 | 2 | 4 | 8 | 8 |
| Profit before tax | 14 | 13 | 2 | -2 | 38 | 42 |
| Tax % | 25% | 28% | 42% | -21% | 18% | |
| Net Profit | 11 | 9 | 1 | -1 | 31 | 34 |
| EPS in Rs | 8.31 | 7.40 | 0.85 | -1.05 | 23.70 | 26.00 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|
| YoY Net Profit Growth (%) | -18.18% | -88.89% | -200.00% | 3200.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -70.71% | -111.11% | 3400.00% |
Modi Naturals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 4 years from 2021-2022 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 12% |
| TTM: | 45% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 49% |
| TTM: | 544% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 53% |
| 3 Years: | 33% |
| 1 Year: | 53% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 11% |
| Last Year: | 29% |
Last Updated: September 5, 2025, 3:51 pm
Balance Sheet
Last Updated: July 25, 2025, 1:00 pm
| Month | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Equity Capital | 13 | 13 | 13 | 13 | 13 |
| Reserves | 55 | 65 | 69 | 77 | 108 |
| Borrowings | 21 | 51 | 142 | 170 | 149 |
| Other Liabilities | 33 | 37 | 38 | 46 | 59 |
| Total Liabilities | 121 | 165 | 263 | 306 | 330 |
| Fixed Assets | 19 | 26 | 27 | 149 | 145 |
| CWIP | 0 | 0 | 91 | 0 | 16 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 102 | 139 | 144 | 157 | 169 |
| Total Assets | 121 | 165 | 263 | 306 | 330 |
Below is a detailed analysis of the balance sheet data for Modi Naturals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 13.00 Cr..
- For Reserves, as of Mar 2025, the value is 108.00 Cr.. The value appears strong and on an upward trend. It has increased from 77.00 Cr. (Mar 2024) to 108.00 Cr., marking an increase of 31.00 Cr..
- For Borrowings, as of Mar 2025, the value is 149.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 170.00 Cr. (Mar 2024) to 149.00 Cr., marking a decrease of 21.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 59.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 46.00 Cr. (Mar 2024) to 59.00 Cr., marking an increase of 13.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 330.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 306.00 Cr. (Mar 2024) to 330.00 Cr., marking an increase of 24.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 145.00 Cr.. The value appears to be declining and may need further review. It has decreased from 149.00 Cr. (Mar 2024) to 145.00 Cr., marking a decrease of 4.00 Cr..
- For CWIP, as of Mar 2025, the value is 16.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 16.00 Cr., marking an increase of 16.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 169.00 Cr.. The value appears strong and on an upward trend. It has increased from 157.00 Cr. (Mar 2024) to 169.00 Cr., marking an increase of 12.00 Cr..
- For Total Assets, as of Mar 2025, the value is 330.00 Cr.. The value appears strong and on an upward trend. It has increased from 306.00 Cr. (Mar 2024) to 330.00 Cr., marking an increase of 24.00 Cr..
However, the Borrowings (149.00 Cr.) are higher than the Reserves (108.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Free Cash Flow | -8.00 | -36.00 | -137.00 | -161.00 | -93.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Debtor Days | 17 | 15 | 17 | 25 | 26 |
| Inventory Days | 72 | 95 | 98 | 125 | 60 |
| Days Payable | 8 | 12 | 21 | 33 | 20 |
| Cash Conversion Cycle | 81 | 98 | 94 | 117 | 66 |
| Working Capital Days | 42 | 34 | 37 | 26 | 14 |
| ROCE % | 14% | 3% | 3% | 19% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 23.25 | -0.89 | 0.93 | 7.38 | 8.31 |
| Diluted EPS (Rs.) | 23.25 | -0.89 | 0.93 | 7.38 | 8.31 |
| Cash EPS (Rs.) | 29.19 | 2.13 | 2.07 | 8.52 | 9.40 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 91.35 | 68.10 | 64.59 | 61.00 | 53.62 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 91.35 | 68.10 | 64.59 | 61.00 | 53.62 |
| Revenue From Operations / Share (Rs.) | 498.19 | 300.47 | 330.24 | 374.75 | 349.78 |
| PBDIT / Share (Rs.) | 43.00 | 7.68 | 5.49 | 12.78 | 13.15 |
| PBIT / Share (Rs.) | 37.12 | 4.51 | 4.26 | 11.66 | 12.06 |
| PBT / Share (Rs.) | 28.33 | -1.30 | 1.47 | 10.23 | 11.04 |
| Net Profit / Share (Rs.) | 23.32 | -1.03 | 0.84 | 7.40 | 8.31 |
| NP After MI And SOA / Share (Rs.) | 23.32 | -1.03 | 0.84 | 7.40 | 8.31 |
| PBDIT Margin (%) | 8.63 | 2.55 | 1.66 | 3.41 | 3.75 |
| PBIT Margin (%) | 7.45 | 1.50 | 1.28 | 3.11 | 3.44 |
| PBT Margin (%) | 5.68 | -0.43 | 0.44 | 2.73 | 3.15 |
| Net Profit Margin (%) | 4.68 | -0.34 | 0.25 | 1.97 | 2.37 |
| NP After MI And SOA Margin (%) | 4.68 | -0.34 | 0.25 | 1.97 | 2.37 |
| Return on Networth / Equity (%) | 25.52 | -1.52 | 1.30 | 12.13 | 15.49 |
| Return on Capital Employeed (%) | 24.71 | 3.32 | 3.09 | 17.91 | 20.85 |
| Return On Assets (%) | 9.40 | -0.45 | 0.40 | 5.66 | 8.67 |
| Long Term Debt / Equity (X) | 0.58 | 0.94 | 1.07 | 0.00 | 0.00 |
| Total Debt / Equity (X) | 1.22 | 1.87 | 1.74 | 0.66 | 0.30 |
| Asset Turnover Ratio (%) | 2.08 | 1.41 | 1.95 | 3.31 | 0.00 |
| Current Ratio (X) | 1.22 | 1.24 | 1.53 | 1.59 | 2.06 |
| Quick Ratio (X) | 0.57 | 0.47 | 0.57 | 0.46 | 0.64 |
| Inventory Turnover Ratio (X) | 5.61 | 3.28 | 3.61 | 4.70 | 0.00 |
| Interest Coverage Ratio (X) | 4.89 | 1.32 | 1.97 | 8.96 | 12.85 |
| Interest Coverage Ratio (Post Tax) (X) | 3.65 | 0.82 | 1.30 | 6.19 | 9.12 |
| Enterprise Value (Cr.) | 601.08 | 422.48 | 433.31 | 295.48 | 112.19 |
| EV / Net Operating Revenue (X) | 0.90 | 1.06 | 1.04 | 0.62 | 0.25 |
| EV / EBITDA (X) | 10.51 | 41.33 | 62.37 | 18.26 | 6.74 |
| MarketCap / Net Operating Revenue (X) | 0.68 | 0.63 | 0.70 | 0.52 | 0.20 |
| Price / BV (X) | 3.75 | 2.81 | 3.61 | 3.23 | 1.36 |
| Price / Net Operating Revenue (X) | 0.68 | 0.63 | 0.70 | 0.52 | 0.20 |
| EarningsYield | 0.06 | -0.01 | 0.00 | 0.03 | 0.11 |
After reviewing the key financial ratios for Modi Naturals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 23.25. This value is within the healthy range. It has increased from -0.89 (Mar 24) to 23.25, marking an increase of 24.14.
- For Diluted EPS (Rs.), as of Mar 25, the value is 23.25. This value is within the healthy range. It has increased from -0.89 (Mar 24) to 23.25, marking an increase of 24.14.
- For Cash EPS (Rs.), as of Mar 25, the value is 29.19. This value is within the healthy range. It has increased from 2.13 (Mar 24) to 29.19, marking an increase of 27.06.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.35. It has increased from 68.10 (Mar 24) to 91.35, marking an increase of 23.25.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.35. It has increased from 68.10 (Mar 24) to 91.35, marking an increase of 23.25.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 498.19. It has increased from 300.47 (Mar 24) to 498.19, marking an increase of 197.72.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 43.00. This value is within the healthy range. It has increased from 7.68 (Mar 24) to 43.00, marking an increase of 35.32.
- For PBIT / Share (Rs.), as of Mar 25, the value is 37.12. This value is within the healthy range. It has increased from 4.51 (Mar 24) to 37.12, marking an increase of 32.61.
- For PBT / Share (Rs.), as of Mar 25, the value is 28.33. This value is within the healthy range. It has increased from -1.30 (Mar 24) to 28.33, marking an increase of 29.63.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 23.32. This value is within the healthy range. It has increased from -1.03 (Mar 24) to 23.32, marking an increase of 24.35.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 23.32. This value is within the healthy range. It has increased from -1.03 (Mar 24) to 23.32, marking an increase of 24.35.
- For PBDIT Margin (%), as of Mar 25, the value is 8.63. This value is below the healthy minimum of 10. It has increased from 2.55 (Mar 24) to 8.63, marking an increase of 6.08.
- For PBIT Margin (%), as of Mar 25, the value is 7.45. This value is below the healthy minimum of 10. It has increased from 1.50 (Mar 24) to 7.45, marking an increase of 5.95.
- For PBT Margin (%), as of Mar 25, the value is 5.68. This value is below the healthy minimum of 10. It has increased from -0.43 (Mar 24) to 5.68, marking an increase of 6.11.
- For Net Profit Margin (%), as of Mar 25, the value is 4.68. This value is below the healthy minimum of 5. It has increased from -0.34 (Mar 24) to 4.68, marking an increase of 5.02.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.68. This value is below the healthy minimum of 8. It has increased from -0.34 (Mar 24) to 4.68, marking an increase of 5.02.
- For Return on Networth / Equity (%), as of Mar 25, the value is 25.52. This value is within the healthy range. It has increased from -1.52 (Mar 24) to 25.52, marking an increase of 27.04.
- For Return on Capital Employeed (%), as of Mar 25, the value is 24.71. This value is within the healthy range. It has increased from 3.32 (Mar 24) to 24.71, marking an increase of 21.39.
- For Return On Assets (%), as of Mar 25, the value is 9.40. This value is within the healthy range. It has increased from -0.45 (Mar 24) to 9.40, marking an increase of 9.85.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.58. This value is within the healthy range. It has decreased from 0.94 (Mar 24) to 0.58, marking a decrease of 0.36.
- For Total Debt / Equity (X), as of Mar 25, the value is 1.22. This value exceeds the healthy maximum of 1. It has decreased from 1.87 (Mar 24) to 1.22, marking a decrease of 0.65.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 2.08. It has increased from 1.41 (Mar 24) to 2.08, marking an increase of 0.67.
- For Current Ratio (X), as of Mar 25, the value is 1.22. This value is below the healthy minimum of 1.5. It has decreased from 1.24 (Mar 24) to 1.22, marking a decrease of 0.02.
- For Quick Ratio (X), as of Mar 25, the value is 0.57. This value is below the healthy minimum of 1. It has increased from 0.47 (Mar 24) to 0.57, marking an increase of 0.10.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.61. This value is within the healthy range. It has increased from 3.28 (Mar 24) to 5.61, marking an increase of 2.33.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 4.89. This value is within the healthy range. It has increased from 1.32 (Mar 24) to 4.89, marking an increase of 3.57.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.65. This value is within the healthy range. It has increased from 0.82 (Mar 24) to 3.65, marking an increase of 2.83.
- For Enterprise Value (Cr.), as of Mar 25, the value is 601.08. It has increased from 422.48 (Mar 24) to 601.08, marking an increase of 178.60.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.90. This value is below the healthy minimum of 1. It has decreased from 1.06 (Mar 24) to 0.90, marking a decrease of 0.16.
- For EV / EBITDA (X), as of Mar 25, the value is 10.51. This value is within the healthy range. It has decreased from 41.33 (Mar 24) to 10.51, marking a decrease of 30.82.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.68. This value is below the healthy minimum of 1. It has increased from 0.63 (Mar 24) to 0.68, marking an increase of 0.05.
- For Price / BV (X), as of Mar 25, the value is 3.75. This value exceeds the healthy maximum of 3. It has increased from 2.81 (Mar 24) to 3.75, marking an increase of 0.94.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.68. This value is below the healthy minimum of 1. It has increased from 0.63 (Mar 24) to 0.68, marking an increase of 0.05.
- For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has increased from -0.01 (Mar 24) to 0.06, marking an increase of 0.07.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Modi Naturals Ltd:
- Net Profit Margin: 4.68%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 24.71% (Industry Average ROCE: 14.31%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 25.52% (Industry Average ROE: 12.9%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.65
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.57
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 15.8 (Industry average Stock P/E: 552.91)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.22
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.68%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Edible Oils & Solvent Extraction | 405, Deepali Building, 92, Nehru Place, New Delhi Delhi 110019 | investors@modinaturals.com http://www.modinaturals.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Anil Modi | Chairman & Managing Director |
| Mr. Akshay Modi | Joint Managing Director |
| Mrs. Aditi Modi | Whole Time Director |
| Mr. Ankit Garg | Independent Director |
| Mrs. Ankita Singal | Independent Director |
| Mr. Udit Jain | Independent Director |
FAQ
What is the intrinsic value of Modi Naturals Ltd?
Modi Naturals Ltd's intrinsic value (as of 09 October 2025) is 349.36 which is 15.00% lower the current market price of 411.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹539 Cr. market cap, FY2025-2026 high/low of 667/320, reserves of ₹108 Cr, and liabilities of 330 Cr.
What is the Market Cap of Modi Naturals Ltd?
The Market Cap of Modi Naturals Ltd is 539 Cr..
What is the current Stock Price of Modi Naturals Ltd as on 09 October 2025?
The current stock price of Modi Naturals Ltd as on 09 October 2025 is 411.
What is the High / Low of Modi Naturals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Modi Naturals Ltd stocks is 667/320.
What is the Stock P/E of Modi Naturals Ltd?
The Stock P/E of Modi Naturals Ltd is 15.8.
What is the Book Value of Modi Naturals Ltd?
The Book Value of Modi Naturals Ltd is 92.8.
What is the Dividend Yield of Modi Naturals Ltd?
The Dividend Yield of Modi Naturals Ltd is 0.00 %.
What is the ROCE of Modi Naturals Ltd?
The ROCE of Modi Naturals Ltd is 18.6 %.
What is the ROE of Modi Naturals Ltd?
The ROE of Modi Naturals Ltd is 29.2 %.
What is the Face Value of Modi Naturals Ltd?
The Face Value of Modi Naturals Ltd is 10.0.